Academic Publications

2016

  1. Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus M. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform 2016, available online 10/29/2016.
  2. Inoue M, Chen P, Siecinski S, Li Q, Steinman L, Gregory SG, Benner E, Shinohara ML. An interferon-B-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage. Nat Neurosci 2016 Nov 7. doi: 10.1038/nn.4421. 
  3. Hall, KS, Cohen, HJ, Pieper, CF, Fillenbaum, GG, Kraus, WE, Huffman, KM, Cornish, MA, Shiloh, A, Flynn, C, Sloane, R, Newby, LK, and Morey, MC. “Physical Performance Across the Adult Life Span: Correlates With Age and Physical Activity.” The journals of gerontology. Series A, Biological sciences and medical sciences (June 29, 2016). PMID   27356977
  4. Wu LT. Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug and Alcohol Dependence. Available online 19 October 2016. http://www.sciencedirect.com/science/article/pii/S0376871616309504
  5. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Corrigendum to “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool” [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97]. Contemp Clin Trials. 2016 Sep 22. pii: S1551-7144(16)30285-3. doi: 10.1016/j.cct.2016.09.001. PMID: 27665683.
  6. McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, Sleiter L, Russell L, Nordeck C, Sharma A, O’Grady KE, Bouk LB, Cushing C, King J, Wahle A,  Schwartz RP. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 2016 Sep 6. doi: 10.7326/M16-0317. PMID: 27595276.
  7. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Design of the NIDA clinical trials network validation study of tobacco, alcohol,  prescription medications, and substance use/misuse (TAPS) tool. Contemp Clin Trials. 2016 Sep;50:90-7. doi: 10.1016/j.cct.2016.07.013. PMID: 27444426; PMCID: PMC5035619.
  8. Zhu H, Wu LT. Trends and Correlates of Cannabis-involved Emergency Department Visits: 2004 to 2011. J Addict Med. 2016 Aug 29. PMID: 27574753.
  9. Mannelli P, Wu LT. Primary care for opioid use disorder. Subst Abuse Rehabil. 2016 Aug 16;7:107-9. doi: 10.2147/SAR.S69715. PMID: 27574479; PMCID: PMC4993411.
  10. Mannelli P, Wu LT. Family substance use screening: less to hide, more to gain. Indian J Med Res. 2016 Jun;143(6):682-684. doi: 10.4103/0971-5916.191920. PMID: 27748291.

2015

  1. Halim SA, Neely ML, Pieper KS, Shah Sh, Kraus WE, Hauser ER, Claiff RM, Granger CB, Newby LK. Simultaneous Consideration of Multiple Candidate Protein Biomarkers for Long-Term Risk for Cardiovascular Disease. Circ Cardiovasc Genet. 2015 Feb;8(1):168-77.  

2014

  1. Hayden KM,  Makeeva OA, Newby LK,  Plassman BL, Markova VV, Dunham A, Romero HR, Melikyan ZA, Germain CM, Welsh-Bohmer KA, Roses A. A Comparison of Neuropsychological Performance Between US and Russia: Preparing for a Global Clinical Trial. Alzheimers Dement. 2014 Nov;10(6):760-8.
  2. Strauss BW, Valentiner EM, Bhattacharya S, Smerek MS, Dunham AA, Newby LK, Miranda ML. Improving population representation through geographic health information systems: mapping the MURDOCK study. Amer J of Trans Res2014, 6.4:402-412.
  3. Romero HR, Welsh-Bohmer KA, Gwyther LP, Edmonds HL, Plassma B, Germain C, McCart M, Hayden KM, Pieper C, Roses AD. Community engagement in diverse populations for Alzheimer’s disease prevention trials. Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):269-74.

2013

  1. Batch BC, Shah SH, Newgard CB, Turer CB, Haynes C, Bain JR, Muehlbauer M, Patel MJ, Stevens RD, Appel LJ, Newby LK, Svetkey LP. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism; 2013 Jul;62(7):961-9.
  2. Evsyukova I, Bradrick SS, Gregory SG, Garcia-Blanco MA. Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6. RNA; 2013 Jan;19(1):103-15. 
  3. Murray JS, Dunson DB, Carin L, Lucas JE. Bayesian Gaussian copula factor models for mixed data. Journal of the American Statistical Association. 2013 108:656-65.
  4. Mayrink VD, Lucas JE. Sparse Latent Factor Models with Interactions: Analysis of Gene Expression DataAnn Appl Stat. 2013;7(2):799–822. DOI: 10.1214/12-AOAS607.
  5. Kraus VB, Feng S, Wang S, White S, Ainslie M, Hellio Le Graverand M, Brett A, Eckstein F, Charles HC. Subchondrial Bone Trabecular Integrity Predicts and Changes Concurrently with Radiographic and MRI Determined Osteoarthritis Progression. Arthritis Rheum. 2013;65(7):1812–21. DOI 10.1002/art.37970

2012

  1. Bhattacharya S, Dunham AA, Cornish MA, Christian VA, Ginsburg GS, Tenenbaum JD, Nahm ML, Miranda ML, Califf RM, Dolor RJ, Newby LK. The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository. Amer J Trans Res. 2012;4(4):458-470.
  2. Lucas JE, Thompson JW, Dubois LG, McCarthy JJ, Tillmann H, Thompson A, Shire N, Hendrickson R, Dieguez F, Goldman P, Schwarz K, Patel K, McHutchison JM, Moseley MA. Metaprotein Expression Modeling for Label-Free Quantitative Proteomics. BMC Bioinformatics. 2012, 13:74 doi:10.1186/1471-2105-13-74.
  3. Tenenbaum JD, Christian V, Cornish MA, Dolor RJ, Dunham AA, Ginsburg GS, Kraus VB, McHutchison JG, Nahm ML, Newby LK, Svetkey LP, Udayakumar K, Califf RM. The MURDOCK Study: A long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. Am J Transl Res. 2012;4(3):291-301.
  4. Kraus VB, Birmingham J, Stabler T, Feng S, Taylor DC, Moorman CT 3rd, Garrett WE, Toth AP. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage. 2012 Apr; 20(4): 271-8. 
  5. Heinzen EL, Depondt C, Cavalleri GL, Ruzzo EK, Walley NM, Need AC, Ge D, He M, Cirulli ET, Zhao Q, Cronin KD, Gumbs CE, Campbell CR, Hong LK, Maia JM, Shianna KV, McCormack M, Radtke RA, O’Conner GD, Mikati MA, Gallentine WB, Husain AM, Sinha SR, Chinthapalli K, Puranam RS, McNamara JO, Ottman R, Sisodiya SM, Delanty N, Goldstein RB. Exome Sequencing Followed by Large-Scale Genotyping Fails to Identify Single Rare Variants of Large Effect in Idiopathic Generalized Epilepsy Am J Hum Genet. 2012 Aug; 91(2):293-302.
  6. Rowell J, Thompson A, Guyton JR, Qian LX, McHutchison JG, McCarthy JJ and Patel K. Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis. Hepatol Int. 2011 Jul 7.
  7. Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, Muehlbauer MJ, Wenner BR, Bain JR, Laferrere B, Gorroochurn P, Teixeira J, Brantley PJ, Stevens VJ, Hollis JF, Appel LJ, Lien LF, Batch B, Newgard CB, Svetkey LP. Branched Chain Amino Acid Levels are Associated with Improvement in Insulin Resistance with Weight LossDiabetologia. 2012 Feb; 55(2):321–30.
  8. Shah SH, Sun J, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, Haynes C, Hauser ER, Kraus WE, Granger CB, Newgard CB, Califf RM, Newby LK, for the MURDOCK Horizon 1 Cardiovascular Disease Investigators. Baseline Metabolomic Profiles Predict Cardiovascular Events in Patients at Risk for Coronary Artery Disease. Am Heart J. 2012 May;163(5):844-50.
  9. Shah AA, Craig DM, Sebek JK, Haynes C, Stevens RC, Muehlbauer MJ, Granger CB, Hauser ER, Newby LK, Newgard CB, Kraus WE, Hughes GC, Shah SH. Metabolic Profiles Predict Asverse Events Following Coronary Artery Bypass Grafting. J Thoracic Cardiovasc Surg. 2012 Apr; 143(4):873-8.
  10. Need AC, McEvoy JP, Gennarelli M, Heinzen EL, Ge D, Maia JM, Shianna KV, He M, Cirulli ET,  Gumbs CE, Zhao Q, Campbell CR, Hong L, Rosenquist P, Putkonen A, Hallikainen T, Repo-Tiihonen E, Tiihonen J, Levy DL, Meltzer HY, Goldstein DB. Exome Sequencing Followed by Large-Scale Genotyping Suggests a Limited Role for Moderately Rare Risk Factors of Strong Effect in Schizophrenia. Am J Hum Genet. 2012 Aug; 91(2):303-312.
  11. Catterall JB, Hsueh MF, Stabler TV, Feng S, McCudden CF, Bolognesi M,  Zuru R, Jordan JM, Renner JB, Kraus VB. Protein Modification by Deamidation Indicates Variations in Joint Extracellular Matrix Turnover. J Biol Chem. 2012 Feb. 10;287(7):4640-51. Epub 2011 Dec 16 PubMed: 22179616, PMC3281605

2011

  1. Cyr D, Lucas JE, Thompson JW, Patel D, Thompson A, Tillmann H, Clark PJ, Moseley MA, McHutchison JG, McCarthy JJ. Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. PLoS One. 2011;6(7):e21854.
  2. Patel K, Lucas J, Thompson JW, Dubois LG, Tillmann H, Thompson A, Uzarski D, Califf RM, Moseley MA, Ginsburg GS, McHutchison JG, McCarthy JJ. High Predictive Accuracy of an Unbiased Proteomic Profile for Sustained Virologic Response in Chronic Hepatitis C Patients. Hepatology. 2011 Jun; 53(6):1809-18.

2010

  1. Shah SH, Granger CB, Hauser ER, Kraus WE, Sun JL, Pieper K, Nelson CL, DeLong ER, Califf RM, Newby LK, for the MURDOCK Horizon 1 Cardiovascular Disease Investigators. Reclassification of Cardiovascular Risk Using Integrated Clinical and Molecular Biosignatures: Design and Rationale of the MURDOCK Horizon 1 Cardiovascular Disease Study. Am Heart J. 2010 Sep;160(3):371-379.e2.
  2. Shah SH, Sun JL, Piper K, Haynes C, Muehlbauer M, Bain JR, Hauser ER, Kraus WE, Newgard, CB, Granger CB, Califf RM, Newby LK. Insulin-like growth factor binding protein (IGFBP) 2: A novel metabolic biomarker strongly predictive of future cardiovascular events. J Am Coll Cardiol. 2010;55(A97):E914
  3. Li JH, Lao XQ, Tillmann HL, Rowell J, Patel K, Thompson A, Suchindran S, Muir AJ, Guyton JR, Gardner SD, McHutchison JG and McCarthy JJ. Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology. 2010;51(6): 1904-11. PMID: 20235331.
  4. McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, Tillman HL, Muir AJ and McHutchison JG. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology. 2010 Jun;138(7):2307-14. PMID: 20176026.
  5. Johnson CM, Nahm M, Shaw RJ, Dunham A, Newby K, Dolor R, Smerek M, Del Fiol G, Zhang J. Can Prospective Usability Evaluation Predict Data Errors? American Medical Informatics Association (AMIA) Symposium Proceedings, 2010.
  6. Beskow LM, Friedman J, Hardy C, Lin L, Weinfurt KP. Simplifying informed consent for biorepositories: stakeholder perspectives. Genetics in Medicine. 2010 Sep;12(9):567-72.
  7. Beskow LM, Friedman JY, Hardy NC, Lin L, Weinfurt KP (2010) Developing a Simplified Consent Form for Biobanking. PLoS ONE. 2010 Oct;5(10): e13302. doi:10.1371/journal.pone.0013302

2009

  1. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J. Gallup D, Ilkayeva O, Wenner BR, Yancy WE, Eisenson H, Musante G, Surwit R, Millington DS, Butler MD, Svetkey LP. A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance. Cell Metabolism. 2009 Apr; 9(4):311-26.
  2. Kraus, VB, S Feng, SC Wang, S White, M Ainslie, A Brett, A Holmes, HC Charles. Trabecular morphometry by fractal signal analysis is a novel marker of osteoarthritis progression. Arthritis Rheum. 2009 Dec; 60(12): 3711-3722.

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.